StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.51+0.21 (+6.36%)

Close on Nov 17, 2026Market cap $30.65MP/E –Yield –

BriaCell Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for BriaCell Therapeutics

BriaCell Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More BriaCell Therapeutics figures

See a number that looks wrong?